[
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-1",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#definitiongeneral536175",
    "clean_content": "Definition / general\n\n* Lymph node enlargement due to proliferation of some or all compartments or cellular components of lymph nodes, reflecting antigenic stimulation* Can be acute or chronic depending on the pathogenic agents"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-2",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#essentialfeatures536176",
    "clean_content": "Essential features\n\n* Lymph node enlargement* Acute: painful or tender; chronic: nontender* 4 architectural patterns: follicular hyperplasia, sinus histiocytosis, interfollicular / mixed and diffuse* Clonal B or T cell proliferations are generally not detected but reactive clonal populations may occur* Lacks significant cytologic or architectural atypia"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-3",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#terminology536177",
    "clean_content": "Terminology\n\n* Reactive lymphoid hyperplasia* Reactive follicular hyperplasia* Diffuse paracortical hyperplasia* Sinus histiocytosis* Acute nonspecific lymphadenitis* Chronic lymphadenitis"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-4",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#icdcoding536178",
    "clean_content": "ICD coding\n\n* ICD-10: [R59.9](https://www.icd10data.com/ICD10CM/Codes/R00-R99/R50-R69/R59-/R59.9) - enlarged lymph nodes, unspecified"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-5",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#epidemiology536179",
    "clean_content": "Epidemiology\n\n* Represents the reaction of lymphoid tissue to intrinsic or environmental antigens* Most lymph node enlargements are reactive* Can occur in any age group and gender* In children, most lymphadenopathies are benign; in adults, chance of malignancy increases with age ([Mayo Clin Proc 2000;75:723](10907389))"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-6",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#sites536180",
    "clean_content": "Sites\n\n* Any lymph node group can be affected depending on the etiology and area of drainage ([Clin Pediatr (Phila) 2011;50:683](21224249))"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-7",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#pathophysiology536181",
    "clean_content": "Pathophysiology\n\n* Lymph nodes filter lymph drained from tributary regions* Antigenic substances reaching the lymph nodes evoke an immune reaction ([Semin Diagn Pathol 2018;35:4](28619469))* Bacteria and fungi cause predominantly inflammatory reactions; viruses and drugs cause predominantly immune reactions* Acute nonspecific lymphadenitis: acute inflammation of the lymph node due to an infectious or inflammatory etiology* Chronic nonspecific lymphadenitis: chronic inflammation of the lymph node in response to a pathogen / antigen, known or unknown"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-8",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Etiology",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#etiology536182",
    "clean_content": "Etiology\n\n* Infections: virus, bacteria, fungi and protozoa* Chemicals: environmental pollution* Drugs: phenytoin, allopurinol, gold, penicillin, quinidine* Altered tissue components: inflammation, tissue necrosis* Inflammatory / autoimmune conditions, such as rheumatoid arthritis* Other antigens or allergens, including vaccines ([Mayo Clin Proc 2000;75:723](10907389), [Iran J Med Sci 2014;39:158](24753638), [Pediatr Clin North Am 2002;49:1009](12430623))"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-9",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#clinicalfeatures536184",
    "clean_content": "Clinical features\n\n* Clinical features reflect the underlying cause* Enlarged lymph nodes ([Am Fam Physician 2016;94:896](27929264))* In acute lymphadenitis, can be painful or tender and nodes may be soft or fluctuant, with or without associated fever, weight loss, malaise, loss of appetite and redness of overlying skin* In chronic lymphadenitis, enlarged lymph nodes are commonly painless ([Mayo Clin Proc 2000;75:723](10907389))"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-10",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#diagnosis536185",
    "clean_content": "Diagnosis\n\n* Clinical examination* Histopathology: biopsy is rarely performed if reactive nature is clinically obvious* In chronic lymphadenitis, biopsy and histopathology evaluation are necessary* Exclusion of specific causes: clinical, laboratory and imaging findings* If suspicious, exclude lymphoid neoplasia by immunohistochemistry, flow cytometry and required genetic studies"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-11",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Laboratory",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#laboratory536186",
    "clean_content": "Laboratory\n\n* Laboratory findings depend on the etiology and nature of the process (acute versus chronic)* Complete blood count (CBC) may show leukocytosis with neutrophilia or lymphocytosis and erythrocyte sedimentation rate (ESR) may be elevated* Confirmatory tests for specific etiologic agents (infectious agents) may be positive"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-12",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#radiologydescription536187",
    "clean_content": "Radiology description\n\n* Enlarged lymph node(s)* Advanced imaging techniques may help to distinguish reactive lymph node enlargement from tumor metastases or other specific lymph node enlargements ([Mol Imaging Biol 2013;15:40](22588595), [Indian J Gastroenterol 2016;35:55](26923374))"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-13",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#prognosticfactors536189",
    "clean_content": "Prognostic factors\n\n* Benign, usually self limiting process with good prognosis* Prognosis depends on the etiology and appropriate and timely management of the cause"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-14",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#casereports536190",
    "clean_content": "Case reports\n\n* 40 year old man who received dasatinib for chronic myeloid leukemia presented with a large axillary mass ([Medicine (Baltimore) 2020;99:e22791](33157925))* 41 year old woman with a history of nasopharyngeal carcinoma and enlarged cervical lymph nodes ([Clin Nucl Med 2022;47:367](34653051))* 57 year old woman with rheumatoid arthritis and generalized lymphadenopathy ([Case Rep Rheumatol 2014;2014:386328](24839573))* 68 year old man with right cheek melanoma and multiple FDG avid lymph nodes in the left axilla ([Clin Nucl Med 2021;46:433](33782318))"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-15",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#treatment536191",
    "clean_content": "Treatment\n\n* Treat the underlying cause"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-16",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Gross description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#grossdescription536193",
    "clean_content": "Gross description\n\n* Enlarged, soft lymph nodes with tan, homogenous cut surfaces* Acute lymphadenitis: suppuration may lead to necrosis and abscess formation* Chronic lymphadenitis: thickened capsule and fibrosis may be obvious ([Walker: Clinical Methods - The History, Physical, and Laboratory Examinations, 3rd Edition, 1990](21250045))"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-17",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Gross images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#grossimages536194",
    "clean_content": "Gross images\n\nContributed by Kathy Smith, PA  \n\n[![enlarged lymph node](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralSmith_01.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralSmith_01.jpg)\n\nEnlarged lymph node\n\n[![Tan, homogenous appearance](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralSmith_02.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralSmith_02.jpg)\n\nTan, homogenous appearance"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-18",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#microscopichistologicdescription536197",
    "clean_content": "Microscopic (histologic) description\n\n* 4 architectural patterns of reactive hyperplasia are described, depending on the etiology: follicular / nodular, sinus histiocytosis, interfollicular / mixed and diffuse\n  + Follicular hyperplasia (most common reactive pattern)\n    - Enlarged follicles, varying in size and shape, may coalesce and display different configurations- Prominent germinal center and mantle zone- Germinal centers show mixed small and large lymphocytes, centrocytes and centroblasts- Centroblasts polarize to the medial pole / medullary side forming the darker zone and centrocytes accumulate at the peripheral pole / capsular side forming the lighter zone ([Immunity 2016;45:471](27653600))- Centroblasts are 3 - 4 times larger than the inactivated lymphocytes and show a narrow rim of basophilic cytoplasm and large, round to oval vesicular nuclei with 1 - 3 prominent peripheral nucleoli- Mitotic figures are frequent- Centrocytes are smaller lymphocytes with scant cytoplasm, cleaved nuclei, clumped chromatin and small or absent nucleoli- Numerous tingible body macrophages are a characteristic feature of follicular hyperplasia ([Semin Diagn Pathol 2018;35:4](28619469), [Am J Surg Pathol 1987;11:866](3499826))- Other cells: plasma cells, T cells and follicular dendritic cells- PD-1+ T cells (T follicular helper cells) are seen predominantly at the periphery of the germinal center ([Ann Diagn Pathol 2020;44:151421](31751845))- Mantle zone: around the light zone, small lymphocytes- Interfollicular areas may show rare transformed cells (immunoblasts), small lymphocytes, plasma cells and high endothelial venules- Monocytoid B cell proliferation may be seen in follicular hyperplasia around cortical sinuses ([Pathol Res Pract 1998;194:559](9779490))+ Sinus histiocytosis\n      - Expansion of sinuses by histiocytes- Common pattern in lymph nodes draining tumor ([Br J Surg 1983;70:317](6860905))+ Interfollicular / mixed patterns\n        - Paracortical hyperplasia: seen usually in viral infections, nodes draining tumors and autoimmune disorders ([Pathol Res Pract 2001;197:237](11358009), [Hum Pathol 1975;6:363](1079509), [APMIS 2001;109:419](11506473))- Mixed small lymphocytes and immunoblasts, with increased vascularity and interdigitating dendritic cells- Granulomatous lymphadenitis: necrotizing, nonnecrotizing or suppurative granulomas depending on the etiology ([Rev Infect Dis 1986;8:322](3726392))+ Diffuse\n          - Architecture may be effaced- Diffuse proliferation of mixed small lymphocytes, immunoblasts and plasma cells ([APMIS 2001;109:419](11506473))- Immunoblasts may rarely mimic Hodgkin / Reed-Sternberg cells* Acute lymphadenitis\n    + Sinus dilatation followed by accumulation of neutrophils, vascular dilatation and edema of the capsule+ Suppurative or necrotizing inflammation may be seen depending on the etiology ([Semin Pediatr Surg 2006;15:99](16616313))* Chronic lymphadenitis\n      + Follicular hyperplasia, prominence of postcapillary venules, increased number of immunoblasts, fibrosis, plasma cells and histiocytes+ Capsule may be inflamed or fibrotic ([Semin Pediatr Surg 2006;15:99](16616313))"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-19",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#microscopichistologicimages536198",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Jayalakshmi Balakrishna, M.D.  \n\n[![Follicular hyperplasia](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna03.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna03.jpg)\n \n[![Follicular hyperplasia](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna04.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna04.jpg)\n\nFollicular hyperplasia\n\n[![Follicular hyperplasia](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna005.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna005.jpg)\n\nFollicular hyperplasia\n\n[![Interfollicular area](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna08.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna08.jpg)\n\nInterfollicular area\n\n  \n\n[![Germinal center dark zone](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna06.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna06.jpg)\n \n[![Germinal center dark zone](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna07.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna07.jpg)\n\nGerminal center dark zone\n\n[![Sinus histiocytosis](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna09.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna09.jpg)\n \n[![Sinus histiocytosis](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna10.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna10.jpg)\n\nSinus histiocytosis\n\n  \n\n[![Granulomatous lymphadenitis](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna11.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna11.jpg)\n\nGranulomatous lymphadenitis\n\n[![Necrosis](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna12.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna12.jpg)\n\nNecrosis\n\n[![Chronic lymphadenitis](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna13.jpeg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna13.jpeg)\n\nChronic lymphadenitis\n\n[![Primary follicle](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna26.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna26.jpg)\n\nPrimary follicle\n\n  \n\n[![Primary follicle](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna27.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna27.jpg)\n \n[![Primary follicle](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna28.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna28.jpg)\n\nPrimary follicle\n\n[![Primary follicle](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna29.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna29.jpg)\n\nPrimary follicle\n\n[![CD20](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna16.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna16.jpg)\n\nCD20\n\n  \n\n[![Germinal center](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna17.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna17.jpg)\n \n[![Germinal center](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna18.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna18.jpg)\n\nGerminal center\n\n[![CD3](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna19.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna19.jpg)\n\nCD3\n\n[![Plasma cells](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna22.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna22.jpg)\n\nPlasma cells\n\n  \n\n[![Plasma cells](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna20.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna20.jpg)\n \n[![Plasma cells](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna21.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna21.jpg)\n\nPlasma cells\n\n[![Immunoblasts](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna23.jpeg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna23.jpeg)\n\nImmunoblasts\n\n[![Polarization of germinal center](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna24.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna24.jpg)\n\nPolarization of germinal center\n\n  \n\n[![Reactive germinal center](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna25.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna25.jpg)\n\nReactive germinal center"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-20",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Cytology description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#cytologydescription536200",
    "clean_content": "Cytology description\n\n* Cellular smears with mixed small and large lymphocytes, tingible body macrophages and other cell types including histiocytes and follicular dendritic cells* In acute lymphadenitis, a prominence of neutrophils may be seen"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-21",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Peripheral smear description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#peripheralsmeardescription536202",
    "clean_content": "Peripheral smear description\n\n* In reactive lymphadenopathy, peripheral smears may show leukocytosis with either lymphocytosis or neutrophilia, depending on the underlying cause"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-22",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Peripheral smear images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#peripheralsmearimages536203",
    "clean_content": "Peripheral smear images\n\nContributed by Jayalakshmi Balakrishna, M.D.  \n\n[![Lymphocytosis](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna14.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna14.jpg)\n\nLymphocytosis\n\n[![Neutrophilic leukocytosis](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna15.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna15.jpg)\n\nNeutrophilic leukocytosis"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-23",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#positivestains536204",
    "clean_content": "Positive stains\n\n* Follicles: positive for pan-B cell markers, such as [CD19](https://www.pathologyoutlines.com/topic/cdmarkerscd19.html), [CD20](https://www.pathologyoutlines.com/topic/cdmarkerscd20.html), [CD22](https://www.pathologyoutlines.com/topic/cdmarkerscd20to29.html#cd22), [CD79a](https://www.pathologyoutlines.com/topic/cdmarkerscd79a.html), [PAX5](https://www.pathologyoutlines.com/topic/stainspax5.html)* Germinal centers: positive for germinal center markers, such as [CD10](https://www.pathologyoutlines.com/topic/cdmarkerscd10.html) and [BCL6](https://www.pathologyoutlines.com/topic/stainsbcl6.html)* Follicular dendritic cells: positive for [CD21](https://www.pathologyoutlines.com/topic/cdmarkerscd21.html), [CD23](https://www.pathologyoutlines.com/topic/cdmarkerscd23.html)* T cells: [CD3](https://www.pathologyoutlines.com/topic/cdmarkerscd3.html), [CD4](https://www.pathologyoutlines.com/topic/cdmarkerscd4.html), [PD-1](https://www.pathologyoutlines.com/topic/stainspd1.html)* Plasma cells: [CD138](https://www.pathologyoutlines.com/topic/cdmarkerscd138.html)* Paracortex (T cells): positive for pan-T cell markers, such as [CD3](https://www.pathologyoutlines.com/topic/cdmarkerscd3.html), [CD2](https://www.pathologyoutlines.com/topic/cdmarkerscd1.html#cd2), [CD5](https://www.pathologyoutlines.com/topic/cdmarkerscd5.html) and [CD7](https://www.pathologyoutlines.com/topic/cdmarkerscd1.html#cd7), mixed [CD4](https://www.pathologyoutlines.com/topic/cdmarkerscd4.html) and [CD8](https://www.pathologyoutlines.com/topic/cdmarkerscd8.html) positive T cells* Immunoblasts: positive for [CD30](https://www.pathologyoutlines.com/topic/cdmarkerscd30.html) ([StatPearls: Histology, Lymph Nodes [Accessed 4 December 2024]](32644479))* [Ki67](https://www.pathologyoutlines.com/topic/stainski67.html): high proliferation rate in the germinal centers with polarization (dark zone with higher rate of proliferation and light zone with lower rate)"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-24",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#negativestains536205",
    "clean_content": "Negative stains\n\n* Germinal center B cells: negative for [BCL2](https://www.pathologyoutlines.com/topic/stainsbcl2.html)"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-25",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Flow cytometry description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#flowcytometrydescription536206",
    "clean_content": "Flow cytometry description\n\n* Mixed B and T cell populations* T cells typically show mixed [CD4](https://www.pathologyoutlines.com/topic/cdmarkerscd4.html)+ and [CD8](https://www.pathologyoutlines.com/topic/cdmarkerscd8.html)+ subsets ([Cytopathology 2022;33:505](35023246), [J BUON 2013;18:739](24065493))* Usually no immunophenotypic aberrancies but rarely clonal [CD10](https://www.pathologyoutlines.com/topic/cdmarkerscd10.html)+ B cell proliferations are detected by flow cytometry ([Am J Clin Pathol 2004;121:464](15080297))\n      + B cells polytypic based on [light chain](https://www.pathologyoutlines.com/topic/stainskappa.html) pattern (except rare cases as above)"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-26",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Flow cytometry images",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#flowcytometryimages536207",
    "clean_content": "Flow cytometry images\n\nContributed by Jayalakshmi Balakrishna, M.D.  \n\n[![B cells](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna30.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna30.jpg)\n \n[![B cells](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna31.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna31.jpg)\n\nB cells\n\n[![T cells](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna32.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna32.jpg)\n \n[![T cells](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna33.jpg)](https://www.pathologyoutlines.com/imgau/lymphnodesreactivegeneralBalakrishna33.jpg)\n\nT cells"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-27",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#molecularcytogeneticsdescription536210",
    "clean_content": "Molecular / cytogenetics description\n\n* Polyclonal pattern of B and T cell gene rearrangements* Negative for cytogenetic or molecular abnormalities"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-28",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#samplepathologyreport536213",
    "clean_content": "Sample pathology report\n\n* Lymph node, left cervical, needle core biopsy:\n  + Reactive lymphoid hyperplasia and no morphologic or immunophenotypic evidence of a lymphoproliferative disorder"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-29",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#differentialdiagnosis536214",
    "clean_content": "Differential diagnosis\n\n* Follicular hyperplasia\n  + [Classic follicular lymphoma](https://www.pathologyoutlines.com/topic/lymphomafollicularnodalusual.html):\n    - Effaced architecture, back to back follicles, invasion of capsule or adjacent structures, no polarization of the follicle, no tingible body macrophages, no well defined mantle zones- Positive for [CD10](https://www.pathologyoutlines.com/topic/cdmarkerscd10.html), [BCL6](https://www.pathologyoutlines.com/topic/stainsbcl6.html) and [BCL2](https://www.pathologyoutlines.com/topic/stainsbcl2.html), monotypic [light chain](https://www.pathologyoutlines.com/topic/stainskappa.html) expression, monoclonal B cell gene rearrangement and presence of t(14;18)+ [In situ follicular neoplasia](https://www.pathologyoutlines.com/topic/lymphomafollicularneoplasiainsitu.html):\n      - No polarization with bright expression of [CD10](https://www.pathologyoutlines.com/topic/cdmarkerscd10.html) and [BCL2](https://www.pathologyoutlines.com/topic/stainsbcl2.html) in involved germinal centers, monotypic [light chain](https://www.pathologyoutlines.com/topic/stainskappa.html) expression, monoclonal B cell gene rearrangement and presence of t(14;18)* Sinus histiocytosis\n    + Expansion of the sinuses with tumor cells\n      - [Melanoma](https://www.pathologyoutlines.com/topic/skintumormelanocyticmelanoma.html):\n        * Positive for [S100](https://www.pathologyoutlines.com/topic/stainss100.html) and melanocytic markers- [Mesothelioma](https://www.pathologyoutlines.com/topic/pleuramesothelioma.html):\n          * Positive for [WT1](https://www.pathologyoutlines.com/topic/stainswt1.html) and other mesothelial markers- [Anaplastic large cell lymphoma](https://www.pathologyoutlines.com/topic/lymphomanonbanaplastic.html):\n            * Positive for T cell markers, [CD30](https://www.pathologyoutlines.com/topic/cdmarkerscd30.html) and may be positive for [ALK1](https://www.pathologyoutlines.com/topic/stainsalk.html)- [Rosai-Dorfman disease](https://www.pathologyoutlines.com/topic/lymphnodessinushistiocytosiswithmassivelymph.html):\n              * Sinuses with accumulation of histiocytes with enlarged, round to oval hypochromatic nuclei and abundant eosinophilic cytoplasm, often containing engulfed intact inflammatory cells known as emperipolesis ([Am J Surg Pathol 2021;45:35](33177341))* [Classic Hodgkin lymphoma (CHL)](https://www.pathologyoutlines.com/topic/lymphomanonBclassic.html):\n      + Architectural effacement with an inflammatory infiltrate containing large atypical cells with complex nuclear features (Hodgkin / Reed-Sternberg cells) in a mixed background of lymphocytes, histiocytes, plasma cells and eosinophils+ Generally morphologically distinct from reactive conditions but cases with partial nodal involvement, primarily interfollicular involvement or more mononuclear Hodgkin / Reed-Sternberg (HRS) forms can create diagnostic challenges+ Prolonged or atypical EBV associated lymphadenitis may develop and be observed on biopsy evaluation ([Mod Pathol 2012;25:1149](22627742))+ [EBV](https://www.pathologyoutlines.com/topic/stainseber1.html)+ CHL can be distinguished based on cytologic atypia; [EBER](https://www.pathologyoutlines.com/topic/stainseber1.html) expression should be exclusive to the HRS cells\n              - Positive: [CD30](https://www.pathologyoutlines.com/topic/cdmarkerscd30.html), [PAX5](https://www.pathologyoutlines.com/topic/stainspax5.html), [CD15](https://www.pathologyoutlines.com/topic/cdmarkerscd15.html), [EBER](https://www.pathologyoutlines.com/topic/stainseber1.html), [EBV LMP1](https://www.pathologyoutlines.com/topic/stainseber1.html), variable dim [CD20](https://www.pathologyoutlines.com/topic/cdmarkerscd20.html)- Negative: [EBV EBNA2](https://www.pathologyoutlines.com/topic/stainsEBNA2.html), other B cell markers* [Immunosuppression related](https://www.pathologyoutlines.com/topic/lymphomapolymorphicimmunedeficiency.html) and [EBV associated lymphoproliferations](https://www.pathologyoutlines.com/topic/lymphnodesebv.html):\n        + May show greater variation in morphology and marker expression+ Morphology may range from hyperplasias to polymorphic lymphoproliferative disorders to morphologic lymphoma+ Caution is advised in this setting, including correlation with clinical and radiographic status, type of immune suppression and whether the proliferation is viral associated ([Leukemia 2022;36:1720](35732829))* Specific causes of lymphadenitis need to be ruled out\n          + Acute:\n            - [Lymphogranuloma venereum](https://www.pathologyoutlines.com/topic/lymphnodesotherinfections.html#lymphogranulomavenereum), [cat scratch disease](https://www.pathologyoutlines.com/topic/lymphnodescatscratch.html), [bubonic plague](https://www.pathologyoutlines.com/topic/lymphnodesotherinfections.html#yersiniapestis), [tularemia](https://www.pathologyoutlines.com/topic/lymphnodesotherinfections.html#tularemia), [anthrax](https://www.pathologyoutlines.com/topic/skinnontumoranthrax.html), [typhoid fever](https://www.pathologyoutlines.com/topic/colonsalmonella.html), **melioidosis**+ Chronic:\n              - [Tuberculosis](https://www.pathologyoutlines.com/topic/lungnontumortb.html), [leprosy](https://www.pathologyoutlines.com/topic/skinnontumorleprosy.html), [atypical mycobacteria](https://www.pathologyoutlines.com/topic/lymphnodesatypicalmycobacteria.html), [syphilis](https://www.pathologyoutlines.com/topic/skinnontumorsyphilis.html), [fungal](https://www.pathologyoutlines.com/topic/lungnontumorotherfungi.html) or [parasitic infections](https://www.pathologyoutlines.com/topic/lungnontumorotherparasites.html):\n                * Special stains for the causative microorganisms will be positive"
  },
  {
    "id": "reactive-lymphadenopathy_48745_1750165661.txt-30",
    "source_document": "reactive-lymphadenopathy_48745_1750165661.txt",
    "parent": "lymph-nodes--spleen-nonlymphoma_41",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/lymphnodesreactivegeneral.html#additionalreferences536215",
    "clean_content": "Additional references\n\n* [Medeiros: Ioachim's Lymph Node Pathology, 5th Edition, 2021](https://www.amazon.com/exec/obidos/ASIN/1451193572/pathologyoutl-20), [Jaffe: Hematopathology, 3rd Edition, 2024](https://www.amazon.com/exec/obidos/ASIN/0323831656/pathologyoutl-20)"
  }
]